| # | Drug | Count |
|---|---|---|
| 0 | RANIBIZUMAB | 11 |
| 1 | AFLIBERCEPT | 4 |
| 2 | ASPIRIN | 2 |
| 3 | ASPIRIN 325 MG | 2 |
| 4 | ASPIRIN 81 MG | 2 |
| 5 | VITAMIN C | 2 |
| 6 | 0XYGEN | 1 |
| 7 | AMLODIPINE BESYLATE | 1 |
| 8 | BRIMONIDINE | 1 |
| 9 | BRIMONIDINE TARTRATE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CYCLOPENTOLATE HYDROCHLORIDE | 1 | 0.0015 |
| 1 | SODIUM HYALURONATE | 1 | 0.0012 |
| 2 | GATIFLOXACIN | 1 | 0.0006 |
| 3 | RANIBIZUMAB | 11 | 0.0004 |
| 4 | TOBRAMYCIN AND DEXAMETHASONE | 1 | 0.0003 |
| 5 | DIFLUPREDNATE | 1 | 0.0003 |
| 6 | IVERMECTIN | 1 | 0.0002 |
| 7 | OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3% | 1 | 0.0001 |
| 8 | OFLOXACIN OTIC SOLUTION | 1 | 0.0001 |
| 9 | OFLOXACIN OTIC | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antiparasitic [EPC] | 1 | 0.0002 |
| 1 | Pediculicide [EPC] | 1 | 0.0002 |
| 2 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |
| 3 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 15 | 0.0001 |
| 4 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 5 | Carbonic Anhydrase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Aminoglycoside Antibacterial [EPC] | 1 | 0.0000 |
| 7 | Tetracycline-class Drug [EPC] | 1 | 0.0000 |
| 8 | Sulfonylurea [EPC] | 1 | 0.0000 |
| 9 | Histamine-2 Receptor Antagonist [EPC] | 1 | 0.0000 |